![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 17, 9, April 25, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Classics
The Purification and Properties of an Abnormal Prothrombin Protein Produced by Dicumarol-treated Cows. A Comparison to Normal Prothrombin
(Nelsestuen, G. L., and Suttie, J. W. (1972) J. Biol. Chem. 247, 8176–8182)
Vitamin K-dependent Carboxylase. Solubilization and Properties
(Esmon, C. T., and Suttie, J. W. (1976) J. Biol. Chem. 251, 6238–6243)
John Weston Suttie was born in LaCrosse, Wisconsin in 1934. He received his B.S., M.S., and Ph.D. from the University of Wisconsin-Madison in 1957, 1958, and 1960, respectively. He then joined the faculty of the university in 1961 and rose through the ranks to eventually become the Katherine Berns Van Donk Steenbock Professor in Nutrition and Director of the Center for Coagulation Research. Suttie also chaired the Department of Nutritional Sciences from 1988 to 1997. He retired in 2002 and is currently an emeritus professor in the Department of Biochemistry at the University of Wisconsin-Madison.
|
Johan Stenflo, who will be the subject of an upcoming JBC Classic, had previously purified a protein from cows that had been treated with the vitamin K antagonist dicumarol (1). The discovery of dicumarol was the subject of a previous JBC Classic on Karl Paul Link (2). Stenflo's protein was chemically similar to prothrombin but was not biologically active. As reported in the first JBC Classic reprinted here, Suttie and his colleague Gary L. Nelsestuen purified the abnormal prothrombin and compared it to normal prothrombin. They found that the two proteins were similar in carbohydrate and amino acid composition, molecular weight, and antibody-antigen reactions, but the inactive prothrombin did not bind calcium to the same degree as the active protein. Thus, they concluded that vitamin K acted by chemically altering prothrombin or by attaching some previously unrecognized prosthetic group and that this action produced the calcium-binding sites on prothrombin. It was eventually shown that the abnormal prothrombin contained 10 glutamate amino acid residues near its amino terminus whereas the normal protein contained 10
-carboxyglutamates (3–5), indicating that vitamin K might play a role in the carboxylation of glutamate. This proposal was later confirmed by Suttie (6).
In the second JBC Classic reprinted here, Suttie and Charles T. Esmon (who will be featured in a future JBC Classic) solubilize the carboxylase that catalyzes the formation of
-carboxyglutamic acid and report on some of the properties of the enzyme system. They found that enzyme activity requires O2 and vitamin K hydroquinone (reduced vitamin K) or vitamin K and NADH. The reaction was independent of ATP and Mg2+ suggesting that the energy for the reaction is derived from the oxidation of the reduced form of vitamin K. It has since been shown that vitamin K is reduced by vitamin K epoxide reductase to form vitamin K hydroquinone, which is then oxidized by
-glutamyl carboxylase. The result of these coupled reactions is the carboxylation of glutamate.
In recognition of his contributions to science, Suttie has received many awards and honors including the 1974 Mead Johnson Award and the 1980 Osborne & Mendel Award from the American Institute of Nutrition, the 2002 Bristol-Myers Squibb/Mead Johnson Award for Distinguished Achievement in Nutrition Research, and the 2004 Conrad A. Elvehjem Award from the American Society for Nutritional Sciences. He was elected to the National Academy of Sciences in 1996 and the American Society for Nutritional Sciences in 2000. Suttie was also President of both the American Institute of Nutrition (1993–1994) and the Federation of American Societies for Experimental Biology (1996–1997), served as Editor of the Journal of Nutrition (1998–2003), and was a member of the Journal of Biological Chemistry editorial board (1981–1986).
REFERENCES
-carboxyglutamic acid as a component of prothrombin. J. Biol. Chem. 249, 6347–6350
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |